In a phase 1 trial by Martin and colleagues, observations at week 6 comparing tirzepatide vs once-daily liraglutide and placebo have shown that the use of the latter, provides a reduction on the desire for high-fat and high-sugar food by lowering activation in the cingulate gyri, hippocampus and orbitofrontal cortex assessed by MRI and blood-oxygen-level at these areas, meaning less appetite, early satiety, and less food craving with more reduction on weight loss at short term (181)
Always consult your provider before starting a new supplement
I feel healthier and more energetic
Weight loss injections have been shown to support fertility, improve insulin regulation, and help manage PCOS symptoms
Endoscopic, histologic, and immunologic characteristics of the digestive mucosa in autistic children with gastrointestinal symptoms